The Times of India - Business (4 hours ago)
New Income Tax Bill: In July 2024, the government announced a review of the Income-tax Act, 1961, aiming to simplify it for taxpayers. A KPMG survey highlights priorities such as dispute simplification, compliance enhancement, and corporate tax structure adjustments.
ReadThe Times of India - Business (5 hours ago)
New Income Tax Bill LIVE: Finance Minister Nirmala Sitharaman is set to table the New Income Tax Bill, which aims to replace the 1961 Income Tax Act. The bill seeks to simplify tax laws while retaining current obligations and minimize disputes.
ReadThe Hindu - Business (6 hours ago)
Vespa has always been more than just a mode of transport since its inception. It's a cultural icon, a symbol of self-expression for many generations, and an inspiration for artists and creators, says Diego Graffi, Chairman and MD, of Piaggio Vehicles Pvt Ltd
ReadThe Hindu - Business (7 hours ago)
For about two-and-a-half years till January 2025, RBI followed a highly unfortunate exchange rate policy. It was very costly for the economy. And sadly it went unnoticed below the radar screen, says Former Chief Economic Advisor (CEA) Arvind Subramanian
ReadThe Hindu - Business (8 hours ago)
Southern States contribute over 30% of India's GDP, with Tamil Nadu and Karnataka emerging as standout performers with high compounded annual growth rates in Gross State Domestic Product (GSDP), says Chief Economic Adviser (CEA) V. Anantha Nageswaran
ReadThe Hindu - Business (10 hours ago)
The urban share of GDP has remained stagnant between 52-55% from 2000-2020. Given that the urban share of the population has continued to increase during this period, this implies that per capita urban income grew slower than rural during this period
ReadThe Times of India - Business (17 hours ago)
Biocon is set for major growth in the next 2-3 years, propelled by new generics and biosimilars. The Viatris acquisition strengthens its position in the U.S. market, with significant market share in some products already achieved. December quarter revenue increased by 14% in biosimilars and research services.
Read